Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   tyrosinemia type 1
  

Disease ID 576
Disease tyrosinemia type 1
Definition
Tyrosinemia caused by mutations in the FAH gene. It is characterized by deficiency of the enzyme fumarylacetoacetate hydrolase. It is the most severe form of tyrosinemia. Signs and symptoms appear early in life and include failure to thrive, vomiting, diarrhea, jaundice, and bleeding tendency. It may result in liver and kidney failure.
Synonym
defic dis fumarylacetoacetase
deficiencies, fumarylacetoacetase
deficiency disease, fumarylacetoacetase
deficiency diseases, fumarylacetoacetase
deficiency of beta-diketonase
deficiency of fumarylacetoacetase
deficiency of fumarylacetoacetase (disorder)
deficiency, fumarylacetoacetase
disease, fumarylacetoacetase deficiency
diseases, fumarylacetoacetase deficiency
fah deficiency
fumarylacetoacetase defic dis
fumarylacetoacetase deficiencies
fumarylacetoacetase deficiency
fumarylacetoacetase deficiency (disorder)
fumarylacetoacetase deficiency disease
fumarylacetoacetase deficiency diseases
hepatorenal tyrosinemia
hepatorenal tyrosinemias
hereditary tyrosinaemia type i
hereditary tyrosinemia type i
hereditary tyrosinemia, type i
hypertyrosinemia, type i
hypertyrosinemias, type i
type i hypertyrosinemia
type i hypertyrosinemias
type i tyrosinemia
type i tyrosinemias
tyrosinaemia type i
tyrosinemia type 1s
tyrosinemia type i
tyrosinemia type i (disorder)
tyrosinemia, hepatorenal
tyrosinemia, type i
tyrosinemias, hepatorenal
tyrosinemias, type i
tyrsn1
Orphanet
OMIM
DOID
UMLS
C0268490
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:3)
C0023895  |  liver disease  |  1
C0019204  |  hepatocellular carcinoma  |  1
C0022568  |  keratitis  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:1)
2184  |  FAH  |  CLINVAR;ORPHANET;UNIPROT
Inferring Gene(Waiting for update.)
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:22)
174  |  AFP  |  2.856  |  DISEASES
210  |  ALAD  |  4.043  |  DISEASES
229  |  ALDOB  |  2.877  |  DISEASES
2730  |  GCLM  |  2.254  |  DISEASES
55788  |  LMBRD1  |  2.752  |  DISEASES
4143  |  MAT1A  |  2.501  |  DISEASES
4359  |  MPZ  |  1.755  |  DISEASES
4540  |  MT-ND5  |  1.995  |  DISEASES
79661  |  NEIL1  |  2.653  |  DISEASES
4926  |  NUMA1  |  1.621  |  DISEASES
5799  |  PTPRN2  |  1.942  |  DISEASES
6161  |  RPL32  |  3.054  |  DISEASES
6288  |  SAA1  |  1.119  |  DISEASES
26278  |  SACS  |  2.144  |  DISEASES
10165  |  SLC25A13  |  3.514  |  DISEASES
788  |  SLC25A20  |  2.476  |  DISEASES
6648  |  SOD2  |  1.4  |  DISEASES
6667  |  SP1  |  1.312  |  DISEASES
6708  |  SPTA1  |  2.583  |  DISEASES
6898  |  TAT  |  3.415  |  DISEASES
7019  |  TFAM  |  1.636  |  DISEASES
2547  |  XRCC6  |  1.506  |  DISEASES
Locus
Symbol | Locus(Total Locus:1)
FAH  |  15q25.1
Disease ID 576
Disease tyrosinemia type 1
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:6)
HP:0001744  |  Splenomegaly
HP:0001402  |  Hepatocellular carcinoma
HP:0006463  |  Rickets of the lower limbs
HP:0002909  |  Generalized aminoaciduria
HP:0002240  |  Hepatomegaly
HP:0006554  |  Acute hepatic failure
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:6)
HP:0000531  |  Corneal crystals  |  2
HP:0000491  |  Corneal inflammation  |  1
HP:0030731  |  Carcinoma  |  1
HP:0001399  |  Liver failure  |  1
HP:0000613  |  Extreme light sensitivity  |  1
HP:0001402  |  Hepatocellular carcinoma  |  1
Disease ID 576
Disease tyrosinemia type 1
Manually Symptom(Waiting for update.)
Text Mined Symptom(Waiting for update.)
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:21)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs11555096NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580180184CT
rs11555096112784912184FAHumls:C0268490UNIPROTStructural and functional analysis of missense mutations in fumarylacetoacetate hydrolase, the gene deficient in hereditary tyrosinemia type 1.0.4527577682001FAH1580180184CT
rs121965073NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580153101AG,T
rs121965074NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580162282CA
rs121965075NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580181048GT
rs121965076NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580181069GT
rs121965077NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580181120AG
rs121965078NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580173143AG
rs370686447NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580168052GA,T
rs771712041NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580172148GA,C
rs781496816NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580168116CT
rs786204551NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580186139A-
rs786204683NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580158171GT
rs80338894NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580158170GT
rs80338895NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580168263GT
rs80338896NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580172143TC,G
rs80338897NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580172240AT
rs80338898NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580173089CT
rs80338899NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580173093GA
rs80338900NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580180172GA
rs80338901NA2184FAHumls:C0268490CLINVARNA0.452757768NAFAH1580180230GA
GWASdb Annotation(Total Genotypes:15)
Chr Pos SNP_Id RefGene EnsemblGene ENCODE_Factor ENCODE_TFBS Chromosome_interaction GTEx_eQTL SNP_TFBS_affinity_GWAS3D SNP_miRNA_target_affinity_PolymiRTS SNP_splicing_effect_Skippy SNP_splicing_effect_MutPred_Splice SNP_ns_protein_effect_dbNSFP SNP_syn_effect_Silva SNP_phosphorylation_effect_PhosSNP PhastCons_score PhyloP_score GERP++_RS Segway_state Ancestral_allele ESP_AF ESP_AFR ESP_AFR ESP_EUR TG_ASN TG_AMR TG_AFR TG_EUR Type Consequence bStatistic EncH3K27Ac EncH3K4Me1 EncH3K4Me3 EncNucleo OMIM Clinvar
1580450328rs1370276NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876NANAchr15,80450001,80460000,chr1,16020001,16030000,8,Hi-Cchr15,80450001,80460000,chr15,82580001,82590000,18,Hi-CNACeh-22,2.7148Mrg2_2302,1.7321Pbx1_3203,1.8878Pknox2_3077,5.0428hoxb3,1.2735NANANANANANA0.000-0.099-0.39TF1CNANANANANANANANATranscript5PRIME_UTR934
1580453730rs8027913NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876TFP.MYCNAchr15,80450001,80460000,chr1,16020001,16030000,8,Hi-Cchr15,80450001,80460000,chr15,82580001,82590000,18,Hi-CNALM140,25.6114LM185,1.4729LM194,2.2634LM199,3.4028PPARG-RXRA,1.8938NANANANANANA0.000-0.454-2.19GM1TNANANANANANANANAIntergenicUPSTREAM934
1580454745rs2114716NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876TFP.FOXA2TFP.FOXA1TFP.GATA3MCV-23NAchr15,80450001,80460000,chr1,16020001,16030000,8,Hi-Cchr15,80450001,80460000,chr15,82580001,82590000,18,Hi-CNABsx_3483,2.0074Dlx1_1741,1.6788Dlx2_2273,2.1012Dlx3_1030,2.8877Gsm1-FL-primary,1.6019NANANANANANA0.0020.036-0.136GE1TNANANANANANANANA
1580460524rs1545119NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876NANAchr15,80460001,80470000,chr15,82580001,82590000,47,Hi-Cchr15,80460001,80470000,chr9,41910001,41920000,267,Hi-Cchr15,80460001,80470000,chr9,122380001,122390000,8,Hi-CNALM9,4.8956LM14,1.8024LM20,4.4157LM22,1.3111LM77,2.8883NANANANANANA0.0000.5621.72TF2GNANANANANANANANAIntergenicDOWNSTREAM
1580462342rs8033974NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876MCV-2NAchr15,80460001,80470000,chr15,82580001,82590000,47,Hi-Cchr15,80460001,80470000,chr9,41910001,41920000,267,Hi-Cchr15,80460001,80470000,chr9,122380001,122390000,8,Hi-CNALM136,10.165LM210,1.343Ar,3.121Ar,76.813FOXF2,2.7779NANANANANANA0.000-0.751-2.14TF2GNANANANANANANANAIntergenicDOWNSTREAM
1580464669rs7180031NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876CHMMTFP.RXRATFP.HNF4ANAchr15,80460001,80470000,chr15,82580001,82590000,47,Hi-Cchr15,80460001,80470000,chr9,41910001,41920000,267,Hi-Cchr15,80460001,80470000,chr9,122380001,122390000,8,Hi-CNALM28,2.1589LM31,1.5242LM58,3.9886LM130,4.2665LM191,2.674NANANANANANA0.000-1.123-4.64TF2ANANANANANANANANA
1580465920rs3752692NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876TFP.CTCFTFP.MYCTFP.RAD21TFP.ZNF263TFP.SMC3TFP.STAT3TFP.CEBPBMCV-113NAchr15,80460001,80470000,chr15,82580001,82590000,47,Hi-Cchr15,80460001,80470000,chr9,41910001,41920000,267,Hi-Cchr15,80460001,80470000,chr9,122380001,122390000,8,Hi-CNACep3-primary,11.4132Ecm22-primary,1.6751Gat3-primary,1.4147Hal9-primary,1.597Hal9-primary,1.5207NANANANANANA0.0010.015-0.132C0ANANANA
1580469025rs8043254NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876MCV-8NAchr15,80460001,80470000,chr15,82580001,82590000,47,Hi-Cchr15,80460001,80470000,chr9,41910001,41920000,267,Hi-Cchr15,80460001,80470000,chr9,122380001,122390000,8,Hi-CNASox17,1.4893TCCCRNNRTGC,11.8778SYATTGTG,3.2141YGTCCTTGR,2.1613YTCCCRNNAGGY,2.337NANANANANANA0.000-0.272-0.988TF1CNANANANANANANANATranscriptINTRONIC
1580470834rs2866592NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876MCV-1NANANALM30,1.8904LM56,6.6097LM159,1.9513LM188,2.5959LM200,1.4344NANANANANANA0.002-0.293-1.13L0TNANANANANANANANATranscriptINTRONIC9344.96
1580471491rs2866593NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876CHMMTFP.FOSTFP.JUNDTFP.JUNNANANACgd2_3490,1.8412Irx2_0900,1.9284Irx3_2226,1.2718Irx4_2242,1.6483Irx5_2385,1.586NANANANANANA0.000-1.271-4.73TF1GNANANANANANANANARegulatoryFeature
1580472243rs2043692NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876MCV-1NANANARpn4-primary,1.9007Sut2-primary,12.3736Ykl222c-DBD-primary,1.3977LM102,1.3114LM227,5.2487NANANANANANA0.0020.7671.94TF2CNANANANANANANANATranscriptINTRONIC93427.60
1580476575rs12594576NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876TFP.CTCFTFP.RAD21NANANALM54,2.0461LM110,3.7918LM161,1.44LM165,2.5206LM229,2.8969NANANANANANA0.000-0.401-1.42GE1GNANANANANANANANARegulatoryFeatureREGULATORY934
1580476793rs7177977NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876TFP.CTCFNANANALM12,1.6672LM197,9.5307LM225,4.8166usp,2.1071PPARG-RXRA,2.0341NANANANANANA0.000-1.216-3.54TF1GNANANANANANANANATranscriptINTRONIC9343.20
1580477571rs8039712NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876NANANANADlx3_1030,1.5513Dlx4_3488,1.4797Gcn4-DBD-primary,1.4108Hlxb9_3422,3.5665Hoxa7_2668,2.2555NANANANANANA0.000-0.569-1.99GE0ANANANA0.0800.1000.0700.0900.060TranscriptINTRONIC9342.00
1580478645rs1049194NM_000137,FAHENST00000407106,ENSG00000103876ENST00000261755,ENSG00000103876NANANANALM2,8.5588LM7,1.4663LM23,2.811LM54,1.4386LM130,15.3639hsa-miR-1238-5p,-0.158000hsa-miR-4481,-0.113000hsa-miR-4745-5p,-0.113000hsa-miR-4758-5p,-0.130000NANANANANA0.000-0.086-0.631TF2TNANANANANANANANATranscript
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:3)
HP ID HP Name MP ID MP Name Annotation
HP:0006554Acute hepatic failureMP:0002628hepatic steatosisan accumulation of fat deposits in the liver
HP:0001402Hepatocellular carcinomaMP:0010367increased spindle cell carcinoma incidencegreater than the expected number of a highly malignant variant of squamous cell carcinoma, occurring in a specific population in a given time period; spindle cell carcinoma shows biphasic proliferation of conventional SCC component and malignant spindle s
HP:0006463Rickets of the lower limbsMP:0004842abnormal large intestine crypts of Lieberkuhn morphologyany structural anomaly of the tubular intestinal glands found in the mucosal membranes of the large intestine
Mapped by homologous gene(Total Items:6)
HP ID HP Name MP ID MP Name Annotation
HP:0002909Generalized aminoaciduriaMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0006554Acute hepatic failureMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0006463Rickets of the lower limbsMP:0012175flat facethe appearance of a flattened surface outline or contour of a normally rounded face of an organism
HP:0002240HepatomegalyMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0001402Hepatocellular carcinomaMP:0013745abnormal eyelid margin morphologyany structural anomaly of the confluence of the mucosal surface of the conjunctiva, the edge of the orbicularis, and the cutaneous epithelium
HP:0001744SplenomegalyMP:0020254decreased collagen leveldecreased level of the main structural protein of the various connective tissues in animals
Disease ID 576
Disease tyrosinemia type 1
Case(Waiting for update.)